Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006.

Brynjolfsson SF, Bjarnarson SP, Mori E, Del Giudice G, Jonsdottir I.

Vaccine. 2008 Aug 18;26(35):4557-62. doi: 10.1016/j.vaccine.2008.05.083. Epub 2008 Jun 17.

PMID:
18597905
2.

Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.

Brynjolfsson SF, Bjarnarson SP, Mori E, Del Giudice G, Jonsdottir I.

Clin Vaccine Immunol. 2011 Nov;18(11):1936-42. doi: 10.1128/CVI.05247-11. Epub 2011 Sep 7.

3.

The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.

Bjarnarson SP, Jakobsen H, Del Giudice G, Trannoy E, Siegrist CA, Jonsdottir I.

Eur J Immunol. 2005 Apr;35(4):1037-45.

4.

Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.

Baudner BC, Verhoef JC, Giuliani MM, Peppoloni S, Rappuoli R, Del Giudice G, Junginger HE.

J Drug Target. 2005 Sep-Nov;13(8-9):489-98.

PMID:
16332574
5.

Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.

Olafsdottir TA, Hannesdottir SG, Giudice GD, Trannoy E, Jonsdottir I.

Scand J Immunol. 2007 Oct;66(4):426-34.

7.

Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

Ciabattini A, Giomarelli B, Parigi R, Chiavolini D, Pettini E, Aricò B, Giuliani MM, Santini L, Medaglini D, Pozzi G.

Vaccine. 2008 Aug 5;26(33):4244-50. doi: 10.1016/j.vaccine.2008.05.049. Epub 2008 Jun 6.

PMID:
18582996
8.

Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults.

de Voer RM, van der Klis FR, Engels CW, Schepp RM, van de Kassteele J, Sanders EA, Rijkers GT, Berbers GA.

Vaccine. 2009 Nov 23;27(50):6974-82. doi: 10.1016/j.vaccine.2009.09.082. Epub 2009 Oct 1.

PMID:
19800445
9.

Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.

Tejedor JC, Moro M, Merino JM, Gómez-Campderá JA, García-del-Rio M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Ruiz-Contreras J, Martin-Ancel A, Roca J, Boceta R, García-Corbeira P, Maechler G, Boutriau D; Spanish 102547 Study Group.

Pediatr Infect Dis J. 2008 Jul;27(7):579-88. doi: 10.1097/INF.0b013e31816b4561.

PMID:
18536619
10.

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.

Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD.

Vaccine. 2003 Sep 8;21(25-26):3837-44.

PMID:
12922117
11.

Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.

Aase A, Naess LM, Sandin RH, Herstad TK, Oftung F, Holst J, Haugen IL, Høiby EA, Michaelsen TE.

Vaccine. 2003 May 16;21(17-18):2042-51.

PMID:
12706694
12.

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

McVernon J, Maclennan J, Buttery J, Oster P, Danzig L, Moxon ER.

Pediatr Infect Dis J. 2002 Aug;21(8):747-53.

PMID:
12192163
13.

Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.

Findlow H, Borrow R, Hardelid P, Newton E, Frankland S, Naylor S, Miller E, Kaczmarski E, Read RC.

Clin Vaccine Immunol. 2011 Mar;18(3):424-9. doi: 10.1128/CVI.00503-10. Epub 2011 Jan 19.

14.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609.

PMID:
19325450
15.

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.

Baudner BC, Balland O, Giuliani MM, Von Hoegen P, Rappuoli R, Betbeder D, Del Giudice G.

Infect Immun. 2002 Sep;70(9):4785-90.

16.

Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.

Borrow R, Goldblatt D, Andrews N, Richmond P, Southern J, Miller E.

J Infect Dis. 2001 Aug 1;184(3):377-80. Epub 2001 Jul 10.

PMID:
11443568
17.

Adjuvants LT-K63 and CpG enhance the activation of dendritic cells in neonatal mice.

Hannesdottir SG, Olafsdottir TA, Giudice GD, Jonsdottir I.

Scand J Immunol. 2008 Nov;68(5):469-75.

PMID:
18946928
18.

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.

Khatami A, Snape MD, Davis E, Layton H, John T, Yu LM, Dull PM, Gill CJ, Odrjlin T, Dobson S, Halperin SA, Langley JM, McNeil SA, Pollard AJ.

Vaccine. 2012 Apr 16;30(18):2831-8. doi: 10.1016/j.vaccine.2012.02.046. Epub 2012 Mar 3.

PMID:
22394992
19.

Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.

Baudner BC, Morandi M, Giuliani MM, Verhoef JC, Junginger HE, Costantino P, Rappuoli R, Del Giudice G.

J Infect Dis. 2004 Mar 1;189(5):828-32. Epub 2004 Feb 18.

PMID:
14976599
20.

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice.

Barchfeld GL, Hessler AL, Chen M, Pizza M, Rappuoli R, Van Nest GA.

Vaccine. 1999 Feb 26;17(7-8):695-704.

PMID:
10067675

Supplemental Content

Support Center